Second UK study to test gout drug as potential COVID-19 treatment

by Reuters
Wednesday, 3 March 2021 12:28 GMT

March 3 (Reuters) - A large British study looking into potential early-stage COVID-19 treatments will begin testing gout medication colchicine and has widened enrolment criteria for the arm of the trial, University of Oxford researchers said on Wednesday.

The anti-inflammatory drug is already being tested in another UK study dubbed RECOVERY, which is the world's largest clinical trial of treatments for patients hospitalised with COVID-19. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D'Silva)

Our Standards: The Thomson Reuters Trust Principles.